R1 RCM Inc. Stock
Price
Target price
€11.40
€11.40
0.890%
0.1
0.890%
€17.21
16.04.24 / Stuttgart Stock Exchange
WKN: A3DM9Y / Symbol: RCM / Name: R1 RCM / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
R1 RCM Inc. Stock
R1 RCM Inc. gained 0.890% compared to yesterday.
R1 RCM Inc. is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
With a target price of 17 € there is a positive potential of 49.12% for R1 RCM Inc. compared to the current price of 11.4 €.
Pros and Cons of R1 RCM Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of R1 RCM Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| R1 RCM Inc. | 0.890% | -3.390% | -8.065% | -15.556% | 16.327% | -46.226% | - |
| Orasure Tech | -1.940% | -6.481% | -19.841% | -17.886% | -32.215% | -39.477% | -42.919% |
| Surgery Partners Inc | -3.330% | -8.661% | -9.375% | -30.120% | -19.444% | -37.297% | 169.392% |
| MicroVision Inc | -0.560% | -11.575% | -21.863% | -30.099% | -45.009% | -85.057% | 39.158% |
Comments
R1 RCM Inc. (NASDAQ: RCM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock.
Show more
Ratings data for RCM provided by MarketBeat
R1 RCM Inc. (NASDAQ: RCM) had its price target lowered by analysts at Guggenheim from $17.00 to $15.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RCM provided by MarketBeat
R1 RCM Inc. (NASDAQ: RCM) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $17.00 price target on the stock.
Show more
Ratings data for RCM provided by MarketBeat
